Literature DB >> 8058226

Vulvar application of lidocaine for pain relief in spontaneous vaginal delivery.

M K Collins1, K B Porter, E Brook, L Johnson, M Williams, C M Jevitt.   

Abstract

OBJECTIVE: To evaluate the effect of topical perineal lidocaine on immediate postpartum perineal pain.
METHODS: Two hundred three volunteers randomly received either 2% lidocaine jelly or chlorhexidine gluconate topically to the perineum during the second stage of labor in a double-blind study. A four-point analogue pain scale was used to rate perineal pain 30 minutes after delivery. Parametric data were evaluated with the unpaired Student t test. Nonparametric data were analyzed using Mann-Whitney, Pearson chi 2, and Mantel-haenzel tests, and forward stepwise logistic regression.
RESULTS: Women receiving topical lidocaine reported less overall perceived pain (48%, P < .05) and less moderate to severe pain (52%, odds ratio 1.83, P < .04) at delivery than those receiving placebo (33 and 67%, respectively). The incidence of perineal lacerations was similar in the two groups. A logistic regression found topical lidocaine and multiparity as significant correlates of diminished peripartum pain (P < .007).
CONCLUSIONS: Topical application of 2% lidocaine gel was associated with decreased pain perception in the immediate postpartum interval. If confirmed by other investigators, this technique may offer improved analgesia while minimizing the injection route with local analgesia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058226

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  1 in total

1.  Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use.

Authors:  Luiz Francisco Jones Soares da Silva; Flavia Almada do Carmo; Vinicius Raphael de Almeida Borges; Lidiane Mota Monteiro; Carlos Rangel Rodrigues; Lúcio Mendes Cabral; Valeria Pereira de Sousa
Journal:  Int J Nanomedicine       Date:  2011-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.